lidocaine has been researched along with Nervous System Disorders in 44 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this population of patients referred for elective cardioversion of atrial fibrillation, high-dose bolus lidocaine was ineffective in converting patients to sinus rhythm." | 9.09 | High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial. ( Bardy, GH; Marrouche, NF; Reddy, RK; Wittkowsky, AK, 2000) |
| "Lidocaine has been used in treatment of patients with refractory headache." | 8.85 | Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review. ( Gil-Gouveia, R; Goadsby, PJ, 2009) |
| "Chronic neurogenic facial pain is commonly resistant to treatment and is often the source of significant patient morbidity." | 6.69 | Chronic neurogenic facial pain: lack of response to intravenous phentolamine. ( Chaudry, A; Keith, DA; Maciewicz, RJ; Scrivani, SJ, 1999) |
| "In 10 cancer patients with cutaneous allodynia, intravenous lidocaine (5 mg/kg body weight) or 0." | 6.66 | Trial of intravenous lidocaine on painful neuropathy in cancer patients. ( Banning, AM; Ellemann, K; Geertsen, P; Jensen, TS; Sjögren, P; Smith, T, 1989) |
| "Both lidocaine an adrenaline at the scheduled doses showed low sensitivity and specificity as a simulated iv epidural test dose." | 5.20 | [Epidural anaesthesia: Simulated intravascular test dose with S(+) ketamine, lidocaine and adrenaline. A prospective, randomized, double blind and placebo controlled study]. ( Errando, CL; Higueras, R; Soriano-Bru, JL, 2015) |
| "In this population of patients referred for elective cardioversion of atrial fibrillation, high-dose bolus lidocaine was ineffective in converting patients to sinus rhythm." | 5.09 | High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial. ( Bardy, GH; Marrouche, NF; Reddy, RK; Wittkowsky, AK, 2000) |
| "Lidocaine has been used in treatment of patients with refractory headache." | 4.85 | Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review. ( Gil-Gouveia, R; Goadsby, PJ, 2009) |
| "Lidocaine and oral analogs were safe drugs in controlled clinical trials for neuropathic pain, were better than placebo, and were as effective as other analgesics." | 4.82 | Systemic administration of local anesthetic agents to relieve neuropathic pain. ( Carr, DB; Challapalli, V; Lau, J; McNicol, ED; Tremont-Lukats, IW, 2005) |
| "Forty consecutive patients with neurological disorders (encephalopathy, autism, and epilepsy) were referred to dental treatment, and 45 sedations were performed; all were sedated with Midazolam (intramuscular 0." | 3.76 | Special care dentistry: Midazolam conscious sedation for patients with neurological diseases. ( Capp, PL; Cillo, MT; de Faria, ME; de Siqueira, JT; Prado, EG; Siqueira, SR, 2010) |
| "Prilocaine is an amide local anesthetic with a duration of action similar to that of lidocaine." | 2.69 | Transient neurologic symptoms after spinal anesthesia: a lower incidence with prilocaine and bupivacaine than with lidocaine. ( Drasner, K; Hampl, KF; Harms, C; Heinzmann-Wiedmer, S; Luginbuehl, I; Schneider, MC; Seeberger, M, 1998) |
| "Mepivacaine seems to be a promising alternative to lidocaine for outpatient surgical procedures because of its similar duration of action." | 2.69 | Transient neurologic symptoms after spinal anesthesia with mepivacaine and lidocaine. ( Chisholm, MF; Liguori, GA; Zayas, VM, 1998) |
| "Chronic neurogenic facial pain is commonly resistant to treatment and is often the source of significant patient morbidity." | 2.69 | Chronic neurogenic facial pain: lack of response to intravenous phentolamine. ( Chaudry, A; Keith, DA; Maciewicz, RJ; Scrivani, SJ, 1999) |
| "In 10 cancer patients with cutaneous allodynia, intravenous lidocaine (5 mg/kg body weight) or 0." | 2.66 | Trial of intravenous lidocaine on painful neuropathy in cancer patients. ( Banning, AM; Ellemann, K; Geertsen, P; Jensen, TS; Sjögren, P; Smith, T, 1989) |
| "Lidocaine has been used for spinal anesthesia since 1948, seemingly without causing concern." | 2.43 | Transient neurologic symptoms after spinal anesthesia with lidocaine versus other local anesthetics: a systematic review of randomized, controlled trials. ( Christiansen, C; Pace, NL; Punjasawadwong, Y; Zaric, D, 2005) |
| "Neuropathic pain has long been recognised as one of the more difficult types of pain to treat; however, with the current emphasis on providing a multidisciplinary assessment and approach to management, more patients will be offered relief of their symptoms and an improved quality of life." | 2.41 | Management strategies for the treatment of neuropathic pain in the elderly. ( Ahmad, M; Goucke, CR, 2002) |
| "Neuropathic pain is challenging to treat, partly because of the systemic side effects of the commonly used medications." | 1.35 | [What is the place of topical analgesia in neuropathic pain?]. ( Besson, M; Desmeules, J; Piguet, V, 2008) |
| "Thrombocytopenia is considered a relative contraindication to the administration of regional anesthesia." | 1.30 | Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm(-3). ( Beilin, Y; Comerford, M; Zahn, J, 1997) |
| " Although drugs can ameliorate certain toxic effects, indiscriminate use of purported antidotes can have deleterious results." | 1.26 | Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review. ( Irwin, HA; Preskorn, SH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (29.55) | 18.7374 |
| 1990's | 15 (34.09) | 18.2507 |
| 2000's | 14 (31.82) | 29.6817 |
| 2010's | 2 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higueras, R | 1 |
| Errando, CL | 1 |
| Soriano-Bru, JL | 1 |
| Park, AJ | 1 |
| Fisch, JM | 1 |
| Fisch, JL | 1 |
| Walters, MD | 1 |
| Besson, M | 1 |
| Desmeules, J | 1 |
| Piguet, V | 1 |
| Gil-Gouveia, R | 1 |
| Goadsby, PJ | 1 |
| Capp, PL | 1 |
| de Faria, ME | 1 |
| Siqueira, SR | 1 |
| Cillo, MT | 1 |
| Prado, EG | 1 |
| de Siqueira, JT | 1 |
| Ahmad, M | 1 |
| Goucke, CR | 1 |
| Silvanto, M | 1 |
| Tarkkila, P | 1 |
| Mäkelä, ML | 1 |
| Rosenberg, PH | 1 |
| Zaric, D | 1 |
| Christiansen, C | 1 |
| Pace, NL | 1 |
| Punjasawadwong, Y | 1 |
| Imbelloni, LE | 1 |
| Beato, L | 1 |
| Challapalli, V | 1 |
| Tremont-Lukats, IW | 1 |
| McNicol, ED | 1 |
| Lau, J | 1 |
| Carr, DB | 1 |
| Lambert, DH | 1 |
| Amir, R | 1 |
| Argoff, CE | 1 |
| Bennett, GJ | 1 |
| Cummins, TR | 1 |
| Durieux, ME | 1 |
| Gerner, P | 1 |
| Gold, MS | 1 |
| Porreca, F | 1 |
| Strichartz, GR | 1 |
| Muguruma, T | 1 |
| Sakura, S | 1 |
| Saito, Y | 1 |
| Evron, S | 1 |
| Gurstieva, V | 1 |
| Ezri, T | 1 |
| Gladkov, V | 1 |
| Shopin, S | 1 |
| Herman, A | 1 |
| Sidi, A | 1 |
| Weitzman, S | 1 |
| Neustein, SM | 1 |
| Preskorn, SH | 1 |
| Irwin, HA | 1 |
| Maloney, JM | 1 |
| Lertora, JJ | 1 |
| Yarborough, J | 1 |
| Millikan, LE | 1 |
| Sotgiu, ML | 1 |
| Biella, G | 1 |
| Castagna, A | 1 |
| Lacerenza, M | 1 |
| Marchettini, P | 1 |
| Schneider, M | 1 |
| Ettlin, T | 1 |
| Kaufmann, M | 1 |
| Schumacher, P | 1 |
| Urwyler, A | 1 |
| Hampl, K | 1 |
| von Hochstetter, A | 1 |
| Christie, JM | 1 |
| Valdes, C | 1 |
| Markowsky, SJ | 1 |
| Ackerman, WE | 1 |
| Kalichman, MW | 1 |
| Moorhouse, DF | 1 |
| Powell, HC | 1 |
| Myers, RR | 1 |
| Beilin, Y | 1 |
| Zahn, J | 1 |
| Comerford, M | 1 |
| Azoulay, D | 1 |
| Adam, R | 1 |
| Pham, P | 1 |
| Salvucci, M | 1 |
| Davoll, S | 1 |
| Bismuth, H | 1 |
| Debuire, B | 1 |
| Lemoine, A | 1 |
| Martínez-Bourio, R | 1 |
| Arzuaga, M | 1 |
| Quintana, JM | 1 |
| Aguilera, L | 1 |
| Aguirre, J | 1 |
| Sáez-Eguilaz, JL | 1 |
| Arízaga, A | 1 |
| Hampl, KF | 1 |
| Heinzmann-Wiedmer, S | 1 |
| Luginbuehl, I | 1 |
| Harms, C | 1 |
| Seeberger, M | 1 |
| Schneider, MC | 1 |
| Drasner, K | 1 |
| Liguori, GA | 1 |
| Zayas, VM | 1 |
| Chisholm, MF | 1 |
| Lee, DS | 1 |
| Bui, T | 1 |
| Ferrarese, J | 1 |
| Richardson, PK | 1 |
| Greenberg, MS | 1 |
| Youngs, EJ | 1 |
| Scrivani, SJ | 1 |
| Chaudry, A | 1 |
| Maciewicz, RJ | 1 |
| Keith, DA | 1 |
| Marrouche, NF | 1 |
| Reddy, RK | 1 |
| Wittkowsky, AK | 1 |
| Bardy, GH | 1 |
| Westhues, M | 1 |
| Malan, MD | 1 |
| Crago, RR | 1 |
| Raskin, NH | 1 |
| Fishman, RA | 1 |
| Drewry, A | 1 |
| Gorman, DF | 1 |
| Ellemann, K | 1 |
| Sjögren, P | 1 |
| Banning, AM | 1 |
| Jensen, TS | 1 |
| Smith, T | 1 |
| Geertsen, P | 1 |
| Petersen, P | 1 |
| Kastrup, J | 1 |
| Zeeberg, I | 1 |
| Boysen, G | 1 |
| Coulter, DM | 1 |
| Yamagiwa, M | 1 |
| Kubo, M | 1 |
| Harada, T | 1 |
| Sakakura, Y | 1 |
| Phillips, OC | 1 |
| Ebner, H | 1 |
| Nelson, AT | 1 |
| Black, MH | 1 |
| Hendrix, GH | 1 |
| Cline, ME | 1 |
| Guntheroth, WG | 1 |
| Chakmakjian, S | 1 |
| Brena, SC | 1 |
| Ricketts, HJ | 1 |
| Wiederhielm, CA | 1 |
| Rudik, VP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain : A Pilot Study[NCT02217267] | Phase 3 | 29 participants (Actual) | Interventional | 2014-08-01 | Completed | ||
| The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic[NCT04043624] | Phase 4 | 80 participants (Anticipated) | Interventional | 2019-08-01 | Recruiting | ||
| Effect of Intravenous Single-bolus Lidocaine Infusion Versus Intravenous Single-bolus Magnesium Sulfate Infusion on Postoperative Pain, Emotional Status and Quality of Life in Patients Undergoing Spine Fusion Surgery[NCT04776369] | Phase 4 | 60 participants (Actual) | Interventional | 2022-05-01 | Active, not recruiting | ||
| A Randomized, Controlled, Double-Blind Trial of 3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty to Compare the Percentage of Patients in Each Group With Early Ambulation[NCT03948386] | Phase 4 | 159 participants (Actual) | Interventional | 2019-05-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
length of hospital stay (NCT03948386)
Timeframe: hospital stay (0-3 days)
| Intervention | hours (Median) |
|---|---|
| Isobaric Bupivacaine | 26 |
| Hyperbaric Bupivacaine | 26 |
| Isobaric Mepivacaine | 22 |
number of patients with dizziness when transitioning from lying down to sitting or standing (NCT03948386)
Timeframe: Postoperative day 2
| Intervention | Participants (Count of Participants) |
|---|---|
| Isobaric Bupivacaine | 11 |
| Hyperbaric Bupivacaine | 7 |
| Isobaric Mepivacaine | 9 |
Number of patients with TNS events occurring. Transient neurological symptoms were defined as new onset of back, buttock, or thigh pain occurring after spinal anesthesia. (NCT03948386)
Timeframe: Postoperative days 0-2
| Intervention | Participants (Count of Participants) |
|---|---|
| Isobaric Bupivacaine | 2 |
| Hyperbaric Bupivacaine | 6 |
| Isobaric Mepivacaine | 5 |
number of patients with inability to urinate within 8 hours of surgery OR a report of distended or painful bladder occurring on postoperative day 0 or 1, either by patient report or on palpation by nursing (NCT03948386)
Timeframe: postoperative day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Isobaric Bupivacaine | 6 |
| Hyperbaric Bupivacaine | 8 |
| Isobaric Mepivacaine | 5 |
Is there a difference between isobaric mepivacaine, hyperbaric bupivacaine, and isobaric bupivacaine when used for spinal anesthesia in primary total hip replacement in percentage of patients that can ambulate within 3.5 hours after spinal anesthesia? (NCT03948386)
Timeframe: 3.5 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Isobaric Bupivacaine | 9 |
| Hyperbaric Bupivacaine | 20 |
| Isobaric Mepivacaine | 35 |
time to return of motor function of the thigh and lower leg (NCT03948386)
Timeframe: Postoperative day 0 (day of surgery)
| Intervention | minutes (Median) |
|---|---|
| Isobaric Bupivacaine | 148 |
| Hyperbaric Bupivacaine | 123 |
| Isobaric Mepivacaine | 109 |
6 reviews available for lidocaine and Nervous System Disorders
| Article | Year |
|---|---|
Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review.
Topics: Adult; Aged; Anesthetics, Local; Bradycardia; Female; Headache; Humans; Hypertension; Lidocaine; Mal | 2009 |
Management strategies for the treatment of neuropathic pain in the elderly.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Capsaicin; Cog | 2002 |
Transient neurologic symptoms after spinal anesthesia with lidocaine versus other local anesthetics: a systematic review of randomized, controlled trials.
Topics: Adult; Anesthesia, Spinal; Anesthetics, Local; Humans; Lidocaine; Nervous System Diseases; Pain; Pat | 2005 |
Systemic administration of local anesthetic agents to relieve neuropathic pain.
Topics: Administration, Oral; Anesthetics, Intravenous; Anesthetics, Local; Flecainide; Humans; Lidocaine; M | 2005 |
Systemic administration of local anesthetic agents to relieve neuropathic pain.
Topics: Administration, Oral; Anesthetics, Intravenous; Anesthetics, Local; Flecainide; Humans; Lidocaine; M | 2005 |
Systemic administration of local anesthetic agents to relieve neuropathic pain.
Topics: Administration, Oral; Anesthetics, Intravenous; Anesthetics, Local; Flecainide; Humans; Lidocaine; M | 2005 |
Systemic administration of local anesthetic agents to relieve neuropathic pain.
Topics: Administration, Oral; Anesthetics, Intravenous; Anesthetics, Local; Flecainide; Humans; Lidocaine; M | 2005 |
The role of sodium channels in chronic inflammatory and neuropathic pain.
Topics: Anesthetics, Local; Calcium Signaling; Chronic Disease; Humans; Inflammation; Lidocaine; Nervous Sys | 2006 |
Neurologic disorders in renal failure (first of two parts).
Topics: Blood-Brain Barrier; Brain Diseases; Cerebrospinal Fluid Proteins; Diazepam; Epilepsy; Humans; Lidoc | 1976 |
12 trials available for lidocaine and Nervous System Disorders
| Article | Year |
|---|---|
[Epidural anaesthesia: Simulated intravascular test dose with S(+) ketamine, lidocaine and adrenaline. A prospective, randomized, double blind and placebo controlled study].
Topics: Adult; Anesthesia, Epidural; Double-Blind Method; Elective Surgical Procedures; Epinephrine; Female; | 2015 |
The influence of ambulation time on the incidence of transient neurologic symptoms after lidocaine spinal anesthesia.
Topics: Adult; Anesthesia, Spinal; Anesthetics, Local; Arthroscopy; Early Ambulation; Female; Humans; Knee; | 2004 |
Lidocaine 2% with or without glucose 8% for spinal anesthesia for short orthopedic surgery.
Topics: Adult; Anesthesia, Spinal; Anesthetics, Local; Female; Glucose; Humans; Lidocaine; Male; Middle Aged | 2005 |
Transient neurological symptoms after isobaric subarachnoid anesthesia with 2% lidocaine: the impact of needle type.
Topics: Aged; Aged, 80 and over; Anesthesia, Spinal; Anesthetics, Local; Equipment Design; Humans; Lidocaine | 2007 |
Acute cyclosporine toxicity after liver transplantation is predicted by the lidocaine monoethylglycinexylidide test in the donor.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Kidney Diseases; Lidocaine; Liver Function Te | 1997 |
Incidence of transient neurologic symptoms after hyperbaric subarachnoid anesthesia with 5% lidocaine and 5% prilocaine.
Topics: Adult; Aged; Anesthesia, Spinal; Atmospheric Pressure; Back Pain; Female; Humans; Lidocaine; Male; M | 1998 |
Transient neurologic symptoms after spinal anesthesia: a lower incidence with prilocaine and bupivacaine than with lidocaine.
Topics: Adult; Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Female; Humans; Lidocaine; Nervous Syste | 1998 |
Transient neurologic symptoms after spinal anesthesia with mepivacaine and lidocaine.
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia, Spinal; Arthroscopy; Back Pain; Double-Blind Meth | 1998 |
Chronic neurogenic facial pain: lack of response to intravenous phentolamine.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anesthetics, Local; Causalgia; Chronic Disease; Facial Pa | 1999 |
High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Dose-Response Relationship, D | 2000 |
Trial of intravenous lidocaine on painful neuropathy in cancer patients.
Topics: Adult; Aged; Double-Blind Method; Electrocardiography; Female; Humans; Injections, Intravenous; Lido | 1989 |
Chronic pain treatment with intravenous lidocaine.
Topics: Double-Blind Method; Humans; Infusions, Intravenous; Lidocaine; Mexiletine; Nervous System Diseases; | 1986 |
26 other studies available for lidocaine and Nervous System Disorders
| Article | Year |
|---|---|
Transient obturator neuropathy due to local anesthesia during transobturator sling placement.
Topics: Adult; Anesthetics, Local; Bupivacaine; Female; Humans; Lidocaine; Nervous System Diseases; Obturato | 2009 |
[What is the place of topical analgesia in neuropathic pain?].
Topics: Administration, Topical; Analgesia; Analgesics; Anesthetics, Local; Humans; Lidocaine; Nervous Syste | 2008 |
Special care dentistry: Midazolam conscious sedation for patients with neurological diseases.
Topics: Adolescent; Adult; Anesthesia, Dental; Anesthetics, Local; Autistic Disorder; Brain Damage, Chronic; | 2010 |
Is TNS really no big deal?
Topics: Anesthesia, Spinal; Anesthetics, Local; Humans; Leg; Lidocaine; Nervous System Diseases; Pain, Posto | 2006 |
Epidural lidocaine induces dose-dependent neurologic injury in rats.
Topics: Analgesia, Epidural; Anesthetics, Local; Animals; Cauda Equina; Dose-Response Relationship, Drug; In | 2006 |
The use of lidocaine for spinal anesthesia.
Topics: Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Equipment Design; Health Knowledge, Attitudes, | 2008 |
Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Child; Dose-Response Relationsh | 1982 |
Plasma concentrations of lidocaine during hair transplantation.
Topics: Adult; Anesthesia, Local; Dizziness; Dose-Response Relationship, Drug; Hair; Humans; Lidocaine; Male | 1982 |
Different time-courses of i.v. lidocaine effect on ganglionic and spinal units in neuropathic rats.
Topics: Animals; Electrophysiology; Ganglia, Sensory; Injections, Intravenous; Lidocaine; Male; Nervous Syst | 1994 |
Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine.
Topics: Anesthesia, Spinal; Female; Humans; Lidocaine; Middle Aged; Nervous System Diseases; Solutions; Suba | 1993 |
Neurotoxicity of lidocaine combined with mexiletine.
Topics: Administration, Oral; Cardiomyopathies; Drug Therapy, Combination; Humans; Injections, Intravenous; | 1993 |
Transient neurologic toxicity after subarachnoid anesthesia with hyperbaric 5% lidocaine.
Topics: Anesthesia, Spinal; Humans; Lidocaine; Nervous System Diseases; Posture; Spina Bifida Occulta; Subar | 1993 |
Relative neural toxicity of local anesthetics.
Topics: Anesthetics, Local; Animals; Etidocaine; Female; Lidocaine; Nervous System Diseases; Procaine; Rats; | 1993 |
Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm(-3).
Topics: Analgesia, Epidural; Analgesia, Obstetrical; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthet | 1997 |
Cauda equina syndrome after incidental total spinal anesthesia with 2% lidocaine.
Topics: Aged; Anesthesia, Spinal; Anesthetics, Local; Cauda Equina; Coronary Artery Bypass; Humans; Lidocain | 1998 |
Atypical odontalgia.
Topics: Anesthetics, Local; Facial Pain; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Nervous | 1998 |
Rate of injection and neurotoxicity of spinal lidocaine.
Topics: Anesthesia, Spinal; Anesthetics, Local; Humans; Lidocaine; Nervous System Diseases | 1999 |
[Local anaesthesia--modern outlook, faults and complications (author's transl)].
Topics: Anesthesia, Local; Bupivacaine; Humans; Lidocaine; Mepivacaine; Nervous System Diseases; Procaine | 1976 |
Anaesthetic considerations in idiopathic orthostatic hypotension and the Shy-Drager syndrome.
Topics: Adult; Anesthesia; Diazepam; Fecal Incontinence; Fentanyl; Humans; Hypotension, Orthostatic; Lidocai | 1979 |
Lidocaine as an adjunct to hyperbaric therapy in decompression illness: a case report.
Topics: Adult; Atmosphere Exposure Chambers; Combined Modality Therapy; Decompression Sickness; Humans; Infu | 1992 |
Adverse reactions to tocainide.
Topics: Anti-Arrhythmia Agents; Drug Eruptions; Female; Humans; Lidocaine; Male; Nervous System Diseases; To | 1985 |
[Effect of topical anesthesia of the pharyngolaryngeal mucosae on abnormal sensation in the throat].
Topics: Adult; Aged; Anesthesia, Local; Female; Humans; Laryngeal Diseases; Lidocaine; Male; Middle Aged; Mu | 1988 |
Neurologic complications following spinal anesthesia with lidocaine: a prospective review of 10,440 cases.
Topics: Adolescent; Adult; Anesthesia, Spinal; Back Pain; Female; Headache; Humans; Lidocaine; Male; Methods | 1969 |
Effects of an unusually large amount of intravenous lidocaine.
Topics: Cardiovascular Diseases; Hemodynamics; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged | 1972 |
Posttraumatic sympathetic dystrophy. Dissociation of pain and vasomotor changes.
Topics: Angiography; Blood Flow Velocity; Child; Epinephrine; Foot; Humans; Injections, Spinal; Leg Injuries | 1971 |
[Clinical aspects, diagnosis and therapy of ganglionitis of the superior cervical vegetative ganglion].
Topics: Adolescent; Adult; Aged; Female; Ganglia, Autonomic; Humans; Lidocaine; Male; Middle Aged; Neck; Ner | 1969 |